Vestibular Symptoms Remain Stable and Improve for Many Meniere's Patients After Cochlear Implant

Most patients with Meniere's disease experience stable or improved vestibular symptoms following cochlear implantation, providing reassurance about surgical outcomes.
A recent study published in the September issue of Otology & Neurotology Open indicates that most patients with Meniere's disease (MD) experience stabilization or improvement in their vestibular symptoms following cochlear implantation (CI) in the affected ear. The research, led by Alexandra M. Arambula, M.D., from the University Hospitals Cleveland Medical Center, analyzed the impact of CI on vestibular symptoms in a retrospective review of 39 patients treated between 2011 and 2024.
Preoperative assessment showed that 51% of patients had moderate to severe vestibular symptoms, while 41% experienced mild symptoms. Post-surgery, approximately 28% of patients reported symptom improvement, 64% remained stable, and about 8% experienced worsening. Notably, patients with mild or no symptoms before surgery were more likely to have stable symptoms afterward, whereas those with more severe symptoms had a higher chance of experiencing improvement.
The study also revealed that patients with moderate or severe preoperative symptoms were more prone to migraines, with 35% affected compared to only 5.3% of patients with mild or no symptoms. Among those with significant symptoms, those without migraines were more likely to see symptomatic improvement.
These findings are relevant for preoperative counseling, as they suggest that cochlear implantation generally does not worsen vestibular symptoms in most patients and can sometimes lead to improvement. The study emphasizes the importance of considering comorbid conditions like migraines when discussing expected outcomes.
While the sample size was relatively small, the results contribute valuable insights into the management of Meniere's disease and the role of cochlear implants in preserving or enhancing vestibular function.
Source: medicalxpress.com
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
EU Approves Controversial Alzheimer's Medication Kisunla
The European Union has approved Kisunla, a new Alzheimer's medication, under strict conditions amid ongoing debates over its effectiveness and safety. Stay informed on the latest developments in Alzheimer's treatment.
HPV's Role in Tumor Development in Rare Nasal Cancers Uncovered
New research uncovers how human papillomavirus (HPV) can drive tumor growth in rare sinonasal cancers, offering insights into targeted treatment options.
Groundbreaking Study Demonstrates Effectiveness of Indoor Mosquito Control in Reducing Dengue Cases
A major clinical trial demonstrates that targeted indoor residual spraying significantly reduces dengue mosquito populations and community-wide disease cases, offering a promising new strategy for dengue prevention.



